α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans

Gerd Heusch; Dietrich Baumgart; Paolo Camici; William Chilian; Luisa Gregorini; Otto Hess; Ciro Indolfi; Ornella Rimoldi

α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans

Gerd Heusch, Dietrich Baumgart, Paolo Camici, William Chilian, Luisa Gregorini, Otto Hess, Ciro Indolfi, Ornella Rimoldi

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

The use of quantitative coronary angiography, combined with Doppler and PET, has recently been directed at the study of α-adrenergic coronary vasomotion in humans. Confirming prior animal experiments, there is no evidence of α-adrenergic coronary constrictor tone at rest. Again confirming prior experiments, responses to α-adrenoceptor activation are augmented in the presence of coronary endothelial dysfunction and atherosclerosis, involving both α₁- and α₂-adrenoceptors in epicardial conduit arteries and microvessels. Such augmented α-adrenergic coronary constriction is observed during exercise and coronary interventions, and it is powerful enough to induce myocardial ischemia and limit myocardial function. Recent studies indicate a genetic determination of α₂-adrenergic coronary constriction.

Original language	English
Pages (from-to)	689-694
Number of pages	6
Journal	Circulation
Volume	101
Issue number	6
Publication status	Published - Feb 15 2000

Keywords

Coronary disease
Ischemia
Microcirculation
Nervous system
Receptors, adrenergic, alpha

ASJC Scopus subject areas

Physiology
Cardiology and Cardiovascular Medicine

Cite this

@article{5cb3b61d04e54f9e92a20f068bb3c6eb,

title = "α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans",

abstract = "The use of quantitative coronary angiography, combined with Doppler and PET, has recently been directed at the study of α-adrenergic coronary vasomotion in humans. Confirming prior animal experiments, there is no evidence of α-adrenergic coronary constrictor tone at rest. Again confirming prior experiments, responses to α-adrenoceptor activation are augmented in the presence of coronary endothelial dysfunction and atherosclerosis, involving both α1- and α2-adrenoceptors in epicardial conduit arteries and microvessels. Such augmented α-adrenergic coronary constriction is observed during exercise and coronary interventions, and it is powerful enough to induce myocardial ischemia and limit myocardial function. Recent studies indicate a genetic determination of α2-adrenergic coronary constriction.",

keywords = "Coronary disease, Ischemia, Microcirculation, Nervous system, Receptors, adrenergic, alpha",

author = "Gerd Heusch and Dietrich Baumgart and Paolo Camici and William Chilian and Luisa Gregorini and Otto Hess and Ciro Indolfi and Ornella Rimoldi",

year = "2000",

month = feb,

day = "15",

language = "English",

volume = "101",

pages = "689--694",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans

AU - Heusch, Gerd

AU - Baumgart, Dietrich

AU - Camici, Paolo

AU - Chilian, William

AU - Gregorini, Luisa

AU - Hess, Otto

AU - Indolfi, Ciro

AU - Rimoldi, Ornella

PY - 2000/2/15

Y1 - 2000/2/15

N2 - The use of quantitative coronary angiography, combined with Doppler and PET, has recently been directed at the study of α-adrenergic coronary vasomotion in humans. Confirming prior animal experiments, there is no evidence of α-adrenergic coronary constrictor tone at rest. Again confirming prior experiments, responses to α-adrenoceptor activation are augmented in the presence of coronary endothelial dysfunction and atherosclerosis, involving both α1- and α2-adrenoceptors in epicardial conduit arteries and microvessels. Such augmented α-adrenergic coronary constriction is observed during exercise and coronary interventions, and it is powerful enough to induce myocardial ischemia and limit myocardial function. Recent studies indicate a genetic determination of α2-adrenergic coronary constriction.

AB - The use of quantitative coronary angiography, combined with Doppler and PET, has recently been directed at the study of α-adrenergic coronary vasomotion in humans. Confirming prior animal experiments, there is no evidence of α-adrenergic coronary constrictor tone at rest. Again confirming prior experiments, responses to α-adrenoceptor activation are augmented in the presence of coronary endothelial dysfunction and atherosclerosis, involving both α1- and α2-adrenoceptors in epicardial conduit arteries and microvessels. Such augmented α-adrenergic coronary constriction is observed during exercise and coronary interventions, and it is powerful enough to induce myocardial ischemia and limit myocardial function. Recent studies indicate a genetic determination of α2-adrenergic coronary constriction.

KW - Coronary disease

KW - Ischemia

KW - Microcirculation

KW - Nervous system

KW - Receptors, adrenergic, alpha

UR - http://www.scopus.com/inward/record.url?scp=0034651799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034651799&partnerID=8YFLogxK

M3 - Article

C2 - 10673263

AN - SCOPUS:0034651799

VL - 101

SP - 689

EP - 694

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 6

ER -

α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this